Abstract:Background Prediction of drug-disease interactions is promising for either drug repositioning or disease treatment fields. The discovery of novel drug-disease interactions, on one hand can help to find novel indictions for the approved drugs; on the other hand can provide new therapeutic approaches for the diseases. Recently, computational methods for finding drug-disease interactions have attracted lots of attention because of their far more higher efficiency and lower cost than the traditional wet experiment methods. However, they still face several challenges, such as the organization of the heterogeneous data, the performance of the model, and so on. Methods In this work, we present to hierarchically integrate the heterogeneous data into three layers. The drug-drug and disease-disease similarities are first calculated separately in each layer, and then the similarities from three layers are linearly fused into comprehensive drug similarities and disease similarities, which can then be used to measure the similarities between two drug-disease pairs. We construct a novel weighted drug-disease pair network, where a node is a drug-disease pair with known or unknown treatment relation, an edge represents the node-node relation which is weighted with the similarity score between two pairs. Now that similar drug-disease pairs are supposed to show similar treatment patterns, we can find the optimal graph cut of the network. The drug-disease pair with unknown relation can then be considered to have similar treatment relation with that within the same cut. Therefore, we develop a semi-supervised graph cut algorithm, SSGC, to find the optimal graph cut, based on which we can identify the potential drug-disease treatment interactions. Results By comparing with three representative network-based methods, SSGC achieves the highest performances, in terms of both AUC score and the identification rates of true drug-disease pairs. The experiments with different integration strategies also demonstrate that considering several sources of data can improve the performances of the predictors. Further case studies on four diseases, the top-ranked drug-disease associations have been confirmed by KEGG, CTD database and the literature, illustrating the usefulness of SSGC. Conclusions The proposed comprehensive similarity scores from multi-views and multiple layers and the graph-cut based algorithm can greatly improve the prediction performances of drug-disease associations.

A Study of Drug-Disease Associations Prediction on Diabetes Literature Knowledge Network

Predicting drug-disease associations with heterogeneous network embedding.

Predicting drug-disease associations based on the known association bipartite network

A Highly Efficient Biomolecular Network Representation Model for Predicting Drug-Disease Associations.

Graph Embedding Based Novel Gene Discovery Associated with Diabetes Mellitus

An effective drug-disease associations prediction model based on graphic representation learning over multi-biomolecular network

Predicting drug-disease associations by network embedding and biomedical data integration.

Learning from low-rank multimodal representations for predicting disease-drug associations

Prediction of Drug-Disease Associations Based on Multi-Kernel Deep Learning Method in Heterogeneous Graph Embedding

Identification of Drug-Disease Associations Using Information of Molecular Structures and Clinical Symptoms Via Deep Convolutional Neural Network

A Deep Learning Model Incorporating Knowledge Representation Vectors and Its Application in Diabetes Prediction

Predicting drug-disease interactions by semi-supervised graph cut algorithm and three-layer data integration

Prediction of adverse drug reactions based on knowledge graph embedding

Gndd: A Graph Neural Network-Based Method For Drug-Disease Association Prediction

Drug-Drug Interaction Predictions Via Knowledge Graph and Text Embedding: Instrument Validation Study

Predicting Potential Drug-Disease Associations Based on Hypergraph Learning with Subgraph Matching

Predicting drug-disease associations through layer attention graph convolutional network

Prediction of Drug-Disease Associations and Their Effects by Signed Network-Based Nonnegative Matrix Factorization

Predicting Drug-Disease Associations Through Similarity Network Fusion and Multi-View Feature Projection Representation.

Drug–disease Associations Prediction Via Multiple Kernel-based Dual Graph Regularized Least Squares

Graph-Based Neural Collaborative Filtering Model for Drug-Disease Associations Prediction